The Marketplace Report: Celebrex Fallout for Pfizer Drug maker Pfizer has agreed to limit advertising of its popular arthritis pain reliever Celebrex, after a clinical study linked the drug to an increased risk of heart attacks and strokes. Hear NPR's Alex Chadwick and Lisa Napoli of Marketplace.

The Marketplace Report: Celebrex Fallout for Pfizer

The Marketplace Report: Celebrex Fallout for Pfizer

  • Download
  • <iframe src="https://www.npr.org/player/embed/4236286/4236287" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Drug maker Pfizer has agreed to limit advertising of its popular arthritis pain reliever Celebrex, after a clinical study linked the drug to an increased risk of heart attacks and strokes. Hear NPR's Alex Chadwick and Lisa Napoli of Marketplace.